Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

931 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Smoking, clopidogrel, and mortality in patients with established cardiovascular disease.
Berger JS, Bhatt DL, Steinhubl SR, Shao M, Steg PG, Montalescot G, Hacke W, Fox KA, Lincoff AM, Topol EJ, Berger PB; CHARISMA Investigators. Berger JS, et al. Among authors: fox ka. Circulation. 2009 Dec 8;120(23):2337-44. doi: 10.1161/CIRCULATIONAHA.109.866533. Epub 2009 Nov 23. Circulation. 2009. PMID: 19933933 Free PMC article. Clinical Trial.
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
Saw J, Brennan DM, Steinhubl SR, Bhatt DL, Mak KH, Fox K, Topol EJ; CHARISMA Investigators. Saw J, et al. J Am Coll Cardiol. 2007 Jul 24;50(4):291-5. doi: 10.1016/j.jacc.2007.01.097. Epub 2007 Jul 10. J Am Coll Cardiol. 2007. PMID: 17659194 Free article. Clinical Trial.
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Booth J, Topol EJ; CHARISMA Investigators. Bhatt DL, et al. Among authors: fox ka. Am Heart J. 2005 Sep;150(3):401. doi: 10.1016/j.ahj.2005.03.017. Am Heart J. 2005. PMID: 16169314 Clinical Trial.
Stroke Outcomes in the COMPASS Trial.
Sharma M, Hart RG, Connolly SJ, Bosch J, Shestakovska O, Ng KKH, Catanese L, Keltai K, Aboyans V, Alings M, Ha JW, Varigos J, Tonkin A, O'Donnell M, Bhatt DL, Fox K, Maggioni A, Berkowitz SD, Bruns NC, Yusuf S, Eikelboom JW. Sharma M, et al. Circulation. 2019 Feb 26;139(9):1134-1145. doi: 10.1161/CIRCULATIONAHA.118.035864. Circulation. 2019. PMID: 30667279 Clinical Trial.
Pulse pressure in acute coronary syndromes: Comparative prognostic significance with systolic blood pressure.
Tan NS, Sarak B, Fox KA, Brieger D, Steg PG, Gale CP, Bhatt DL, Spencer FA, Grondin FR, Goodman SG, Yan AT; Canadian GRACE/GRACE-2 and CANRACE Investigators. Tan NS, et al. Among authors: fox ka. Eur Heart J Acute Cardiovasc Care. 2019 Jun;8(4):309-317. doi: 10.1177/2048872617700871. Epub 2017 Mar 30. Eur Heart J Acute Cardiovasc Care. 2019. PMID: 28357882
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial.
Vanassche T, Verhamme P, Anand SS, Shestakovska O, Fox KA, Bhatt DL, Avezum A, Alings M, Aboyans V, Maggioni AP, Widimsky P, Berkowitz SD, Yusuf S, Connolly SJ, Eikelboom JW, Bosch J. Vanassche T, et al. Among authors: fox ka. Eur J Prev Cardiol. 2020 Feb;27(3):296-307. doi: 10.1177/2047487319882154. Epub 2019 Oct 15. Eur J Prev Cardiol. 2020. PMID: 31615291 Clinical Trial.
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
Alfredsson J, Neely B, Neely ML, Bhatt DL, Goodman SG, Tricoci P, Mahaffey KW, Cornel JH, White HD, Fox KA, Prabhakaran D, Winters KJ, Armstrong PW, Ohman EM, Roe MT; TRILOGY ACS Investigators. Alfredsson J, et al. Among authors: fox ka. Heart. 2017 Aug;103(15):1168-1176. doi: 10.1136/heartjnl-2016-310090. Epub 2017 Apr 5. Heart. 2017. PMID: 28381584 Clinical Trial.
Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
White HD, Westerhout CM, Alexander KP, Roe MT, Winters KJ, Cyr DD, Fox KA, Prabhakaran D, Hochman JS, Armstrong PW, Ohman EM; TRILOGY ACS investigators. White HD, et al. Among authors: fox ka. Eur Heart J Acute Cardiovasc Care. 2016 Jun;5(3):231-42. doi: 10.1177/2048872615581502. Epub 2015 Apr 20. Eur Heart J Acute Cardiovasc Care. 2016. PMID: 25897147 Clinical Trial.
Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.
Mallat Z, Steg PG, Benessiano J, Tanguy ML, Fox KA, Collet JP, Dabbous OH, Henry P, Carruthers KF, Dauphin A, Arguelles CS, Masliah J, Hugel B, Montalescot G, Freyssinet JM, Asselain B, Tedgui A. Mallat Z, et al. Among authors: fox ka. J Am Coll Cardiol. 2005 Oct 4;46(7):1249-57. doi: 10.1016/j.jacc.2005.06.056. J Am Coll Cardiol. 2005. PMID: 16198839 Free article.
931 results